LMR Partners’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

LMR Partners’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,000	Closed	-$261K	–	1239
2023 Q1	$261K	Hold	25,000	–	–	﹤0.01%	819
2022 Q4	$255K	Buy	+25,000	New	+$253K	﹤0.01%	972

LMR Partners's LVAC Position: Q2 2023 in Review

LMR Partners sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 25,000 shares — an estimated $261K sold.

LMR Partners first reported a position in LVAC in Q4 2022 and held it in 2 quarters. The position peaked at $261K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

LMR Partners reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
LMR Partners sold 25,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $261K.
LMR Partners first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 2 quarters.
LMR Partners's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $261K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on LMR Partners's 13F filing for Q2 2023, filed 14 Aug 2023.